Caitong International Asset Management Co., Ltd
Position in NBIX — Neurocrine Biosciences Inc
CIK 1963355
HONG KONG, K3
Position in NBIX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$73,247
-$146,731 QoQ
Shares Held
556
-64.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Caitong International Asset Management Co., Ltd holds $1,680,439 across 33 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
21,290 | $752,814 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
12,037 | $249,888 | |
| 3 | LQDA |
Liquidia Corp
|
5,491 | $207,230 | |
| 4 | AKBA |
Akebia Therapeutics, Inc.
|
103,652 | $144,076 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
4,441 | $106,273 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
1,382 | $81,911 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
556 | $73,247 | |
| 8 | HROW |
Harrow, Inc.
|
524 | $18,476 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,247 | 556 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $219,978 | 1,551 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $49,438 | 447 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $955 | 7 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||